Sex differences in the psychopharmacological treatment of depression. - Wikidata - wikimedia - TriplyDB

Sex differences in the psychopharmacological treatment of depression.

Sex differences in the psychopharmacological treatment of depression.

http://www.wikidata.org/entity/Q37618539

about

Chronic Treatment with Fluoxetine Induces Sex-Dependent Analgesic Effects and Modulates HDAC2 and mGlu2 Expression in Female Mice.

P2860

Q47150462-9198F224-DF9F-487B-AC26-95C680E18D5F

P2860

Sex differences in the psychopharmacological treatment of depression.

http://www.wikidata.org/entity/Q37618539

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sex differences in the psychopharmacological treatment of depression.

@en

Sex differences in the psychopharmacological treatment of depression.

@nl

type

label

Sex differences in the psychopharmacological treatment of depression.

@en

Sex differences in the psychopharmacological treatment of depression.

@nl

prefLabel

Sex differences in the psychopharmacological treatment of depression.

@en

Sex differences in the psychopharmacological treatment of depression.

@nl

P1433

Q37618539-9B369D43-06AB-48EB-B4D1-C5F0F93E4BA0

P1476

Q37618539-3EC5BDE6-A9EF-4E1D-A71A-30082A87C6FA

P2093

Q37618539-4ADC9244-F019-4964-B1E4-F72A57DB58CC

Q37618539-61FC3E72-EC92-4DE6-981B-54FAE307EA58

Q37618539-D95800B8-1829-4607-BC4D-47FA5916A45A

P275

Q37618539-67038FC7-8263-40C1-9A93-23160240D2FF

P2860

Q37618539-02031C12-D311-4F17-B153-ECD84EB5AC66

Q37618539-03E55C7B-6E02-440C-B8D0-00BEB8C67C5F

Q37618539-075E4D72-6D4E-43EF-BBCD-88EF79BBC586

Q37618539-0A03E6F2-AB2B-4DBF-A3A6-4F17A14103FE

Q37618539-0B0C0C56-33DD-4130-A4F0-4A24B17401D0

Q37618539-0C33C66D-8725-43B0-9059-630D7BA995F4

Q37618539-0C56031D-7FF2-4E9C-9325-9563C8761E1C

Q37618539-101EF461-B5F7-4867-A965-A60C4AD1104C

Q37618539-1159FB06-F584-4E74-9C56-69481D58BE5E

Q37618539-1459D2A5-7A5D-4BB2-AFC3-4EBD26096632

P304

Q37618539-9165F7D5-E892-490A-9FBF-9049DEC9E71E

P31

Q37618539-8221BB23-7191-4588-AEDD-84EE17C1D23F

Q37618539-98F83620-5995-4B09-9B84-38112C237B4A

P433

Q37618539-E29D3CB7-38BD-4500-BBF3-85FDD0D79D1D

P478

Q37618539-E2F459BB-8898-4B5F-A1D4-E9D767F23EFF

P5008

Q37618539-C3B455BB-ACA9-47FA-BFC0-2A65252ABD37

P577

Q37618539-330920B9-E828-4C20-888B-D26BF7E9E494

P698

Q37618539-B0A8A2F7-C778-45D7-B588-0CC3C105C35E

P921

Q37618539-72955C83-834A-41D7-91F6-A11AAF8FFB45

Q37618539-83E97E98-0E73-4F31-9FD7-F6B628EF16A6

P932

Q37618539-57C32F2E-9762-4E32-9C54-12A5FEB9D3AE

P1433

Dialogues in Clinical Neuroscience

P1476

Sex differences in the psychopharmacological treatment of depression.

@en

P2093

John J Sramek

http://www.w3.org/2001/XMLSchema#string

Michael F Murphy

http://www.w3.org/2001/XMLSchema#string

Neal R Cutler

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.

Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.

Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.

Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder.

Gender differences in depression and antidepressant pharmacokinetics and adverse events.

Clinical pharmacokinetics of mirtazapine.

Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications.

Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.

P304

447-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28179816

http://www.w3.org/2001/XMLSchema#string

P921

mental depression

P932

5286730

http://www.w3.org/2001/XMLSchema#string